MG-ZG122

· Shanghai Mabgeek Biotech.Co.Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MG-ZG122, covering 2025-07-08 to 2025-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects [Phase 2]